Genetic and perinatal factors as risk for childhood type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 20, Issue 6, 2004, Pages 429-437

  Larsson, Karin ^a   Elding Larsson, Helena ^b   Cederwall, Elisabeth ^c   Kockum, Karin ^d   Neiderud, Jan ^e   Sjölad, Sture ^b   Lindberg, Bengt ^b   Lernmark, Barbro ^b   Cilio, Corrado ^b   Ivarsson, Sten A ^b   Lernmark, A ^b,f  

^a CENTRAL HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Angelholm Hospital   (Sweden)

^d Ystad Hospital   (Sweden)

^e HELSINGBORG HOSPITAL   (Sweden)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoimmunity; Blood incompatibility; Gestational infections; HLA; Islet autoantibodies; Transplacental transfer

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; INSULIN ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ALLELE; AUTOIMMUNITY; BIRTH WEIGHT; BLOOD GROUP INCOMPATIBILITY; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; DELIVERY; GENETIC RISK; GESTATION PERIOD; HIGH RISK PATIENT; HLA SYSTEM; HUMAN; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; MATERNAL AGE; NEWBORN PERIOD; PANCREAS ISLET BETA CELL; PERINATAL PERIOD; POPULATION RESEARCH; PREDICTION; PREGNANCY; PRENATAL EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELATIVE; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SWEDEN; UMBILICAL CORD BLOOD;

AUTOIMMUNITY; BLOOD GROUP INCOMPATIBILITY; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFECTION; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 19944399061     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.506     Document Type: Review

References (97)

1. Notkins AL, Lernmark AA.. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 2001; 108: 1247-1252.
2. Bingley PJ, Williams AJ, Gale EA.. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials. Diabetes Care 1999; 22: 1796-1801.
3. Winter WE, Harris N, Schatz DA.. Immunological markers in the diagnosis and prediction of autoimmune type 1a diabetes. Clinical Diabetes 2002; 20: 183.
4. Bingley PJ, Christie MR, Bonifacio E, et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304-1310.
5. Hämälainen AM, Ilonen J, Simell O, et al. Prevalence and fate of type 1 diabetes-associated autoantibodies in cord blood samples from newborn infants of non-diabetic mothers. Diabetes Metab Res Rev 2002; 18: 57-63.
6. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM.. Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers. Diabetes 1997; 46 1701-1710.
7. Kulmala P, Rahko J, Savola K, et al. Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren [In Process Citation]. Diabetologia 2000; 43: 457-464. 498th centile. Subjects at risk for rapid progression to Type I diabetes have two or more AAbs at or greater than the 499. 458th centile, 2000.
8. LaGasse JM, Brantley MS, Leech NJ, et al. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care 2002; 25: 505-511.
9. Schlosser M, Strebelow M, Wassmuth R, et al. The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals. J Clin Endocrinol Metab 2002; 87: 2254-2261.
10. Tuomilehto J, Zimmet P, Mackay IR, et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 1994; 343: 1383-1385.
11. Ivarsson SA, Ackefors M, Carlsson A, et al. Glutamate decarboxylase antibodies in non-diabetic pregnancies precedes insulin-dependent diabetes in the mother but not necessarily in the offspring. Autoimmunity 1997; 26: 261-269.
12. Dahlquist G, Blom L, Tuvemo T, Nyström L, Sandström A, Wall S.. The Swedish Childhood Diabetes Study - results from a nine year case register and one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 1989; 32: 2-6.
13. Douek IF, Gillespie RM, Bingley PJ, Gale EA.. Diabetes in the parents of children with Type I diabetes. Diabetologia 2002; 45 495-501.
14. Menser MA, Forrest JM, Honeyman MC, Burgess JA.. Diabetes, HLA-antigens and congenital rubella. Lancet 1974; 2: 1508-1509.
15. Forrest JM, Menser MA, Burgess JA.. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971; ii: 332-334.
16. Ginsberg-Fellner F, Witt ME, Fedun B, et al. Diabetes mellitus and autoimmunity in patients with congenital rubella syndrome. Rev Infect Dis 1985; 7: 170-176.
17. McIntosh EDG, Menser MA.. A fifty-year follow-up of congenital rubella. Lancet 1992; 340: 414-415.
18. Freij BJ, South MA, Sever JL.. Maternal rubella and the congenital rubella syndrome. Clin Perinatol 1988; 15: 247-257.
19. Dahlquist G, Ivarsson S, Lindberg B, Forsgren M.. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. Diabetes 1995; 44: 408-413.
20. Dahlquist GG.. Viruses and other perinatal exposures as initiating events for beta-cell destruction. Ann Med 1997; 29 413-417.
21. Hyöty H, Hiltunen M, Knip M, et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study. Diabetes 1995; 44: 652-657.
22. Dahlquist G, Frisk G, Ivarsson SA, Svanberg L, Forsgren M, Diderholm H.. Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 1995; 38: 1371-1373.
23. Fuchtenbusch M, Irnstetter A, Jager G, Ziegler AG.. No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun 2001; 17: 333-340.
24. Bock T, Pedersen CR, Volund A, Pallesen CS, Buschard K.. Perinatal determinants among children who later develop IDDM. Diabetes Care 1994; 17: 1154-1157.
25. Dahlquist G, Gustavsson KH, Holmgren G, et al. The incidence of diabetes mellitus in Swedish children 0-14 years of age. Acta Pædiatr Scand 1982; 71: 7-14
26. Dahlquist G, Blom L, Holmgren G, et al. The epidemiology of diabetes in Swedish children 0-14 years old a six-year prospective study. Diabetologia 1985; 28: 802-808.
27. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000; 23: 1516-1526.
28. Green A, Patterson CC. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 2001; 44(Suppl 3): B3-B8.
29. Pundziute-Lycka A, Dahlquist G, Nyström L, et al. and The Swedish Childhood Diabetes Study G. Type I diabetes in the 0-34 years group in Sweden. Diabetologia 2002; 45: 783-791.
30. Graham J, Hagopian WA, Kockum I, et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002; 51: 1346-1555.
31. Cox NJ, Wapelhorst B, Morrison VA, et al. Seven Regions of the Genome Show Evidence of Linkage to Type 1 Diabetes in a Consensus Analysis of 767 Multiplex Families. Am J Hum Genet 2001; 69: 4.
32. Nerup J, Pociot F. A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions. Am J Hum Genet 2001; 69: 1301-1313.
33. Awata T, Hagura R, Urakami T, Kanazawa Y. Age-dependent HLA genetic heterogeneity of IDDM in Japanese patients. Diabetologia 1995; 38: 748-749.
34. Caillat-Zucman A, Garchon H-J, Timsit J, et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992; 90: 2242-2250.
35. Graham J, Kockum I, Breslow N, Lernmark AA, Holmberg E. A comparison of three statistical models for IDDM associations with HLA. Tissue Antigens 1996; 48: 1-14.
36. Herr M, Dudbridge F, Zavattari P, et al. Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21. Hum Mol Genet 2000; 9: 1291-1301.
37. Cucca F, Lampis R, Frau F, et al. The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. Human Immunology 1995; 43: 301-308.
38. Undlien DE, Friede T, Rammensee HG, et al. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 1997; 46: 143-149.
39. Sanjeevi CB, Hagopian WA, Landin-Olsson M, et al. Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8. Tissue Antigens 1998; 51: 281-286.
40. Lie BA, Todd JA, Pociot F, et al. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet 1999; 64: 793-800.
41. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 1990; 322: 1836-1882.
42. Graham J, Kockum I, Sanjeevi CB, et al. Negative association between type 1 diabetes and HLA DQB1*0602- DQA1* 0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group. Eur J Immunogenet 1999; 26: 117-127.
43. Ilonen J, Simell O, Knip M, Åkerblom HK. Screening for genetic IDDM risk and prevention trials in infancy. Diabetes Metab Rev 1998; 14: 188-189.
44. Kimpimaki T, Kulmala P, Savola K, et al. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2002; 87: 4572-4579.
45. Robles DT, Eisenbarth GS, Wang T, et al. Identification of Children with Early Onset and High Incidence of Anti-islet Autoantibodies. Clin Immunol 2002; 102: 217-224.
46. Kimpimaki T, Kupila A, Hämälainen AM, et al. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab 2001; 86: 4782-4788.
47. Dahlquist G, Blom L, Lönnberg G. The Swedish Childhood Diabetes Study - a multivariate analysis of risk determinants for diabetes in different age groups. Diabetologia 1991; 34: 757-762.
48. Lorenzen T, Pociot E, Hougaard P, Nerup J. Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 1994; 37: 321-327.
49. Tillil H, Köbberling J. Age-corrected empirical genetic risk estimates for first-degree relatives of IDDM patients. Diabetes 1987; 36: 93-99.
50. Yu L, Chase HP, Falorni A, Rewers M, Lernmark AA, Eisenbarth GS. Sexual dimorphism in transmission to offspring of expression of islet autoantibodies. Diabetologia 1995; 38: 1353-1357.
51. Petrovsky N, Kyvik KO, Bonnevie-Nielsen V, Beck-Nielsen H, Green A, Harrison LC. Evidence from twins for acquired cellular immune hyperactivity in type 1 diabetes. Immunology 2002; 106: 584-589.
52. Hagopian WA, Karlsen AE, Gottsäter A, et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) showed 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 1993; 91: 368-374.
53. Froguel P, Velho G. Molecular Genetics of Maturity-onset Diabetes of the Young. Trends Endocrinol Metabol 1999; 10: 142-146.
54. Kobayashi T, Oka Y, Katagiri H, et al. Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243. Diabetologia 1996; 39: 1196-1200.
55. Dahlquist G, Källen B. Maternal-child blood group incompatibiity and other perinatal events increased the risk for early-onset type 1 (insulin-dependent) diabetes melllitus. Diabetologia 1992; 35: 671-675.
56. Lorenzen T, Pociot F, Stilgren L, et al. Predictors of IDDM recurrence risk in offspring of Danish IDDM patients. Danish IDDM Epidemiology and Genetics Group. Diabetologia 1998; 41: 666-673.
57. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull 2001; 60: 5-20.
58. Dahlquist G, Bennich SS, Kallen B. Intrauterine growth pattern and risk of childhood onset insulin dependent (type I) diabetes: population based case-control study. BMJ 1996; 313: 1174-1177.
59. Stene LC, Magnus P, Lie RT, Sovik O, Joner G. Birth weight and childhood onset type 1 diabetes: population based cohort study. BMJ 2001; 322: 889-892.
60. Blom L, Dahlquist G, Nyström L, Sandström A, Wall S. The Swedish childhood diabetes study-social and perinatal determinants for diabetes in childhood. Diabetologia 1989; 32: 7-13.
61. Dahlquist GG, Patterson C, Soltesz G. Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 1999; 22: 1698-1702.
62. Bingley PJ, Douek IF, Rogers CA, Gale EA. influence of maternal age at delivery and birth order on risk of type 1 diabetes in childhood: prospective population based family study. Bart's-Oxford Family Study Group. BMJ 2000; 321: 420-424.
63. Jones M, Swerdlow A, Gill L, Goldacre M. Pre-natal and early life risk factors for childhood onset diabetes mellitus: a record linkage study. Int J Epidemiol 1998; 27: 444-449.
64. Menser MA, Forrest JM, Bransby RD. Rubella infection and diabetes mellitus. Lancet 1978; i: 57-60.
65. Visalli N, Sebastiani L, Adorisio E, et al. Environmental risk factors for type 1 diabetes in Rome and province. Arch Dis Child 2003; 88: 695-698.
66. Viskari HR, Roivainen M, Reunanen A, et al. Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes 2002; 51: 2568-2571.
67. Stene LC, Magnus P, Lie RT, Sovik O, Joner G, Diabetes NC. Group. S: No association between preeclampsia or cesarean section and incidence of type 1 diabetes among children: a large, population-based cohort study. Pediatr Res 2003; 54: 487-490.
68. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark AA. Inheritance of MHC class II genes in IDDM studied in population-based affected and control families. Diabetologia 1994; 37: 1105-1112.
69. Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Persson B, Lernmark A. Stable GAD65 Autoantibody Epitope Patterns in Type 1 Diabetes Children Five Years after Onset. J Autoimmun 2002; 18: 49-53.
70. Berzina L, Ludvigsson J, Sadauskaite-Kuehne V, Nelson N, Shtauvere-Brameus A, Sanjeevi CB. DR3 is associated with type 1 diabetes and blood group ABO incompatibility. Ann N Y Acad Sci 2002; 958 345-348.
71. Elfving MA, Lindberg BA, Landin-Olsson M, Hampe CS, Lernmark AA, Ivarsson SA. Islet Cell Autoantibodies in Cord Blood from Children with Blood Group Incompatibility or Hyperbilirubinemia. Autoimmunity 2003; 36: 111-115.
72. Blom L, Nyström L, Dahlquist G. The Swedish childhood diabetes study: Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 1991; 34: 176-181.
73. Lipman TH, Chang Y, Murphy KM. The epidemiology of type 1 diabetes in children in Philadelphia 1990-1994: evidence of an epidemic. Diabetes Care 2002; 25: 1969-1975.
74. Hummel M, Fuchtenbusch M, Schenker M, Ziegler AG. No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study. Diabetes Care 2000; 23: 969-974.
75. DeStefano F, Mullooly JP, Okoro CA, et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics 2001; 108: E112.
76. Virtanen SM, Rasanen L, Aro A, et al. Feeding in infancy and the risk of type 1 diabetes mellitus in Finnish children. The 'Childhood Diabetes in Finland' Study Group. Diabet Med 1992; 9 815-819.
77. Lindberg B, Ivarsson SA, Landin-Olsson M, Sundkvist G, Svanberg L, Lernmark A. Islet autoandbodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age [see comments]. Diabetologia 1999; 42: 181-187.
78. Hämälainen AM, Ronkainen MS, Akerblom HK, Knip M. Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk. J Clin Endocrinol Metab 2000; 85: 4249-4253.
79. Ludvigsson J, Wahlberg J. Diabetes-related autoantibodies in cord blood from children of healthy mothers have disappeared by the time the child is one year old. Ann N Y Acad Sci 2002; 958: 289-292.
80. Stanley HM, Norris JM, Barriga K, et al. Is presence of islet autoantibodies at birth associated with development of persistent islet autoimmunity? The Diabetes Autoimmunity Study in the Young (DAISY). Diabetes Care 2004; 27: 497-502.
81. Hämälainen AM, Savola K, Kulmala PK, Koskela P, Akerblom HK, Knip M. Disease-associated autoantibodies during pregnancy and at birth in families affected by type 1 diabetes. Clin Exp Immunol 2001; 126: 230-235.
82. Rewers M. Islet autoantibodies in cord blood: maternal, fetal, or neither?. Diabetes Metab Res Rev 2002; 18: 2-4.
83. Hämälainen AM, Knip M. Autoimmunity and familial risk of type 1 diabetes. Curr Diabet Rep 2002; 2: 347-353.
84. Koczwara K, Bonifacio E, Ziegler AG. Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 2004; 53: 1-4.
85. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark AA, Sundkvist G. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched controls. Diabetologia 1989; 32: 387-395.
86. Carlsson AK, Axelsson IE, Borulf SK, Bredberg AC, Ivarsson SA. Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics 2001; 107: 42-45
87. Agardh D, Agardh E, Landin-Olsson M, Gaur LK, Agardh CD, Lernmark A. Inverse relationship between GAD65 antibody levels and severe retinopathy in younger type 1 diabetic patients. Diabetes Res Clin Pract 1998; 40: 9-14.
88. Bazzigaluppi E, Lampasona V, Barera G, et al. Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease. J Autoimmun 1999; 12:51-56.
89. Norris JM, Barriga K, Klingensmith G, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003;290:1713-1720.
90. Dahlquist GG, Blom LG, Persson L-AA, Sandström AIM. S.G.I. W: Dietary factors and the risk of developing insulin dependent diabetes in childhood. BMJ 1990; 300: 1302-1306.
91. Akerblorn HK, Savilahti E, Saukkonen TT, Paganus A, Virtanen SM, Teramo K. The case for elimination of cow's milk in early infancy in the prevention of Type 1 diabetes. Diabetes Metab Rev 1994; 9 456-462.
92. Vaarala O, Knip M, Paronen J, et al. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes 1999; 48: 1389-1394.
93. Thernlund GM, Dahlquist G, Hansson K, et al. Psychological stress and the onset of IDDM in children. 1995; 18.
94. Blom L, Persson LA, Dahlquist G. Growth velocity and development of insulin-dependent diabetes mellitus Diabetologia 1992; 35: 528-533.
95. EURODIAB. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia 1999; 42: 51-54.
96. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
97. Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002; 51: 3353-3361.